Effect of Eucommia ulmoides capsule on 24-hour blood pressure rhythm in patients with essential hypertension

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged 40-75 years, male or female;
•2. Meet the diagnostic criteria of essential hypertension;
•3. 24-hour blood pressure rhythm is non-spoon type;
•4. The regimen of western medicine for hypertension is stable (more than 3 months);
•5. Voluntarily participate in the trial and sign the informed consent form.

•1. People who are known or suspected to be allergic to experimental drugs and their components;
•2. Patients with familial hypertension, malignant hypertension, hypertensive emergency, hypertensive crisis and hypertensive encephalopathy;
•3. There is evidence of secondary hypertension, including but not limited to the following diseases: unilateral or bilateral renal artery stenosis, polycystic kidney disease, aldosteronism, coarctation of the aorta, Cushing syndrome, pheochromocytoma.
•4. Gastrointestinal lesions or gastrointestinal surgery may affect drug absorption or excretion, such as gastroenterectomy, active gastrointestinal inflammation within nearly 3 months, ulcers or gastrointestinal bleeding;
•5. Lifestyle with day and night reversal, or irregular sleep patterns;
•6. People with a history of alcohol or drug abuse;
•7. Inability to cooperate because of neurological or mental disorders;
•8. Pregnant, lactating women or people with recent fertility plans;
•9. The researchers do not think it is appropriate to participate in this clinical trial;
•10. They have participated in other clinical trials within 3 months before the trial.

发起方

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science